Corcept Therapeutics (NQ: CORT )

28.14 USD +0.52 (+1.88%)

Official Closing Price Updated: 4:57 PM EST, Jan 15, 2021 Add to My Watchlist

Price and Volume

Volume	608,100
Open	27.62
Bid (Size)	27.80 (6)
Ask (Size)	29.87 (13)
Prev. Close	27.62
Today's Range	27.48 - 28.36
52wk Range	9.700 - 28.36
Shares Outstanding	115,235,013
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

10 Health Care Stocks Showing Unusual Options Activity In Today's Session

January 11, 2021

This unusual options alert can help traders track potentially big trading opportunities. Traders often look for circumstances when the ...

Corcept Therapeutics Sees Its Composite Rating Rise To 96

December 11, 2020

On Friday, Corcept Therapeutics got an upgrade for its IBD SmartSelect Composite Rating from 94 to 96.

Performance

YTD	+7.86%	+7.86%
1 Month	+7.16%	+7.16%
3 Month	+58.98%	+58.98%
6 Month	+66.80%	+66.80%
1 Year	+120.19%	+120.19%

More News

Stocks That Hit 52-Week Highs On Friday

January 15, 2021

The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges

January 15, 2021

Stocks That Hit 52-Week Highs On Thursday

December 24, 2020

Stocks That Hit 52-Week Highs On Wednesday

December 23, 2020

The Daily Biotech Pulse: Supernus Issues Positive ADHD Readout, Sorrento Files For Emergency Use Authorization For Rapid COVID-19 Test, Inhibikase To Make Wall Street Debut

December 23, 2020

Stocks That Hit 52-Week Highs On Tuesday

December 22, 2020

The Daily Biotech Pulse: FDA Nod For Amgen's Biosimilar, Moderna's Vaccine Vote, Mesoblast Sinks On Data

December 18, 2020

Stocks That Hit 52-Week Highs On Thursday

December 17, 2020

The Daily Biotech Pulse: MacroGenics Breast Cancer Drug Wins FDA Approval, Adcom Test Awaits Moderna, Virios To Make Wall Street Debut

December 17, 2020

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.